Calgary, Alberta
The Government of Canada continues to make significant investments in Canada's biomanufacturing and life sciences sector by prioritizing innovative solutions and long-term domestic biomanufacturing capacity.
Today, the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, announced a contribution of $15 million to support Northern RNA's $50 million project through the Strategic Innovation Fund. The proposed three-year project aims to expand Northern RNA's biomanufacturing capacity, including by establishing a facility compliant with good manufacturing practice (GMP) to produce lipids that are a critical component for mRNA vaccines and therapies.
This project aligns with Canada's Biomanufacturing and Life Sciences Strategy and aims to make Canada's vaccine supply chain more resilient by securing domestic lipid production. Through this project, Northern RNA will maintain 50 jobs, create 100 new jobs and hire students for 195 co-op terms.
